(19)
(11) EP 4 277 645 A1

(12)

(43) Date of publication:
22.11.2023 Bulletin 2023/47

(21) Application number: 22743556.7

(22) Date of filing: 09.06.2022
(51) International Patent Classification (IPC): 
A61K 38/08(2019.01)
A61P 17/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/08; A61P 17/06
(86) International application number:
PCT/IB2022/055386
(87) International publication number:
WO 2023/111695 (22.06.2023 Gazette 2023/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 16.12.2021 IN 202141058681

(71) Applicant: Isanaka, Ramakrishna Reddy
Hyderabad Telangana 500034 (IN)

(72) Inventor:
  • Isanaka, Ramakrishna Reddy
    Hyderabad Telangana 500034 (IN)

(74) Representative: Haseltine Lake Kempner LLP 
Bürkleinstrasse 10
80538 München
80538 München (DE)

   


(54) A STABLE ANTI-ANGIOGENIC AND ANTI-INFLAMMATORY PHARMACEUTICAL FORMULATION AND PHARMACEUTICAL COMBINATION FOR TREATMENT AND PREVENTION OF PSORIASIS